Definitive Contract HHSN261201300067C
Award Date 9/25/13
Potential Completion Date 9/24/16
Potential Value $997K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92111, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Nanocomposix, Inc. The $200,000.00 fixed-price contract is for the development of "Surface Enhanced Fluorescence Nanotags for Ultrasensitive Multiplexed Assay Systems." As a small business manufacturer of engineered nanoparticles, Nanocomposix has previously received prime federal contracts and...
- This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, for the development of "small hollow nanodelivery vehicles for cancer treatment." The fixed-price contract has a ceiling value of $200,000.00 and a period of performance ending on March 30, 2010. Nanocomposix has previously performed prime contracts and subcontracts for...
- <p>This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Air Force Materiel Command to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, for the development of passive nanoparticle coatings. Nanocomposix has previously provided products and services to other federal agencies such as the Department of Health and Human Services and the Department of Defense. This contract is set aside for small businesses.</p>
- This is a $999,999.99 cost-plus-fixed-fee contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for a Small Business Innovation Research (SBIR) Phase II program with a target completion date of February 27, 2019. Nanocomposix has previously supported the Department of Defense and Department of Health and Human Services through prime federal contracts and subcontracts, delivering products and...
- This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Air Force Materiel Command to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the development of passive nanoparticle coatings with high visible luminous transmittance and near-infrared blocking capabilities. Nanocomposix has prior experience as both a prime contractor and subcontractor on federal contracts, including work for the Department of...
- This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
- <p>This contract was awarded by the National Cancer Institute, a civilian agency, to Nanoparticle Biochem, Inc., a for-profit organization and manufacturer of goods. The $998,293.57 cost-plus-fixed-fee contract is for the development of in vivo compatible and readily injectable gold nanoconstructs for tumor therapy. The contract was set aside for a small business and has an ultimate completion date of August 26, 2015.</p>